Skip to Content

Loading Video...

Digital Features

How a Cancer Diagnosis Reframed Julie Sweet’s Approach Work and Leadership

September 09, 2025 20:15 PM UTC
- Updated September 09, 2025 20:19 PM UTC

In this segment of Fortune 500:Titans and Disruptors of Industry Accenture CEO Julie Sweet opens up about how a breast cancer diagnosis reshaped her perspective and sharpened her resolve. She reflects on saying “yes” to a stretch role that would set her on the path to CEO, and on how decisive leadership has become her trademark in moments of uncertainty.

show more